ETA-DOC-0004·Compound index·Rev 1·Methodology v0.1Provisional — reviewer not yet appointed
compound index · L, page 3 of 5 · methodology v0.1 · reviewer not yet appointed
Compound index · L ETA-DOC-0004

Compound index — L

887 substances begin with L. 2 of them carry an Etalyn grade; the remainder are marked not yet graded, which is a statement about Etalyn’s coverage and not about the substance. This page shows 200 of them, Lavendula angustifolia… – Lilium Longiflorum Bulb.

US-DRUGListed as a marketed drug substance in the United StatesEU-MEDActive substance in a centrally authorised EU medicineEU-HERBSubject of an EU herbal monographUS-CSAScheduled under the US Controlled Substances ActCA-NHPLicensed supplement ingredient in CanadaEU-CLAIMAppears in the EU nutrition and health claims registerEU-NOVELAppears in the EU novel food catalogueETALYNEtalyn has graded a claim about this substance
Lavendula angustifolia (Lavender) flower extract CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-008561
Lavendula angustifolia (Lavender) flower/leaf/stem CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-008562
Lawsonia Inermis Flowering TOP US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Increased Histamine Release [PE]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008563
Lazertinib US-DRUG Not yet graded
US: nda
Class as recordedBreast Cancer Resistance Protein Inhibitors [MoA]; Cytochrome P450 3A4 Inhibitors [MoA]; Kinase Inhibitor [EPC]; Kinase Inhibitors [MoA]
Earliest US approval2024
Market presence2 US product listings · 1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008564
lazertinib mesilate monohydrate EU-MED Not yet graded
EU medicine: Authorised
Class as recordedL01EB09
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-008565
Lazulite CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-008566
Lb.rhamnosus CA-NHP Not yet graded
CA licensed ingredient
Market presence5 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-008567
LCZ-696 US-DRUG Not yet graded
US: bulk ingredient
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008568
Lead CA-NHPUS-DRUG Not yet graded
CA licensed ingredientUS: unapproved homeopathic
Class as recordedAcetylcholine Release Inhibitor [EPC]; Acetylcholine Release Inhibitors [MoA]; Acidifying Activity [MoA]; Adrenocorticotropic Hormone [CS]
Market presence163 US product listings · 7 Canadian licensed products
Recorded fromCA-NHP, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-008569
Lead Monosilicate US-DRUG Not yet graded
US: unapproved homeopathic
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008570
Lebrikizumab EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bla
Class as recordedD11AH10; Interleukin-13 Antagonist [EPC]; Interleukin-13 Antagonists [MoA]
Market presence5 US product listings · 1 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-008571
Lebrikizumab-Lbkz US-DRUG Not yet graded
Earliest US approval2024
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008572
Lecanemab EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bla
Class as recordedAmyloid Beta-directed Antibody Interactions [MoA]; Amyloid Beta-directed Antibody [EPC]; N06DX04
Market presence6 US product listings · 1 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-008573
Lecanemab-Irmb US-DRUG Not yet graded
US: bla
Class as recordedAmyloid Beta-directed Antibody Interactions [MoA]; Amyloid Beta-directed Antibody [EPC]
Earliest US approval2023
Market presence2 US product listings · 2 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008574
Leccinum aurantiacum EU-NOVEL Not yet graded
Not novel in food
Parts in scopeFruiting body
Recorded fromEU-NOVEL — 1 of 7 registers
Etalyn identifierETA-C-008575
Leccinum versipelle EU-NOVEL Not yet graded
Not novel in food
Parts in scopeFruiting body
Recorded fromEU-NOVEL — 1 of 7 registers
Etalyn identifierETA-C-008576
Leccinum vulpinum EU-NOVEL Not yet graded
Not novel in food
Parts in scopeFruiting body
Recorded fromEU-NOVEL — 1 of 7 registers
Etalyn identifierETA-C-008577
Lecithin CA-NHPEU-CLAIM Not yet graded
EU claims 0 authorised / 7 refusedCA licensed ingredient
Market presence899 Canadian licensed products
Claims examined by the EU — wording reproduced, not Etalyn’s.
Claim as submittedRulingBasisOpinion
“Necessary for normal growth, wholesome mental and physical development 2. Helps maintain functions and structure of the body and organ cell membranes 3. Lecithin is found in every human cell and it participates in various vitally important processes”Non-authorisedArt.13(1)EFSA opinion
“It promotes the correct function of the nervous system. To maintain optimal mental and cognitive performance.”Non-authorisedArt.13(1)EFSA opinion
“It promotes the correct function of the nervous system. To maintain optimal mental and cognitive performance.”Non-authorisedArt.13(1)EFSA opinion
“Lecithin (a phospholipid containing choline) supports memory and concentration.”Non-authorisedArt.13(1)EFSA opinion
“Necessary for the metabolism of fat.”Non-authorisedArt.13(1)EFSA opinion
“Strengthens the immune system of the body”Non-authorisedArt.13(1)EFSA opinion
“Lecithin helps to maintain normal function of cardo-vascular system.”Non-authorisedArt.13(1)EFSA opinion
Recorded fromCA-NHP, EU-CLAIM — 2 of 7 registers
Etalyn identifierETA-C-008578
Lecithin -/phosphatidyl choline EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
Claim as submittedRulingBasisOpinion
“Promotes the good heart functioning and a balanced level of blood lipids.”Non-authorisedArt.13(1)EFSA opinion
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-008579
lecithin phosphatidyl choline EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
Claim as submittedRulingBasisOpinion
“Helps to keep normal cholesterol level”Non-authorisedArt.13(1)EFSA opinion
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-008580
Lecithin, Soybean US-DRUG Not yet graded
US: otc monograph final
Class as recordedAllergens [CS]; Ammonium Ion Binding Activity [MoA]; Blood Coagulation Factor [EPC]; Calcium [CS]
Market presence8 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008581
Lecithine de soja: soy lecithin EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
Claim as submittedRulingBasisOpinion
“Usually recognized to act in case of hypercholesterolemia; Usually recognized to help rate cholesterol stabilization.”Non-authorisedArt.13(1)EFSA opinion
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-008582
Ledebouriella divaricata CA-NHP Not yet graded
CA licensed ingredient
Market presence19 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-008583
Ledebouriella seseloides CA-NHP Not yet graded
CA licensed ingredient
Market presence4 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-008584
Ledipasvir EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bulk ingredient
Class as recordedBreast Cancer Resistance Protein Inhibitors [MoA]; Hepatitis C Virus NS5A Inhibitor [EPC]; Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC]; J05AX65
Earliest US approval2014
Market presence9 US product listings · 2 FDA applications · 1 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-008585
Ledum CA-NHP Not yet graded
CA licensed ingredient
Market presence4 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-008586
Ledum palustre CA-NHP Not yet graded
CA licensed ingredient
Market presence141 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-008587
Ledum Palustre Twig US-DRUG Not yet graded
US: drug for further processing
Class as recordedAcidifying Activity [MoA]; Allergens [CS]; Ammonium Ion Binding Activity [MoA]; Analogs/Derivatives [Chemical/Ingredient]
Market presence80 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008588
Ledum Palustre Whole US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Bee Venoms [CS]; Calculi Dissolution Agent [EPC]; Cell-mediated Immunity [PE]
Market presence7 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008589
Lefamulin Acetate EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: drug for further processing
Class as recordedCytochrome P450 3A Inhibitors [MoA]; Cytochrome P450 3A4 Inhibitors [MoA]; Diterpenes [CS]; J01XX
Earliest US approval2019
Market presence3 US product listings · 2 FDA applications · 1 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-008590
Leflunomide EU-MEDUS-DRUG Not yet graded
EU medicine: Authorised, LapsedUS: anda
Class as recordedAntirheumatic Agent [EPC]; L04AA13; L04AK01
Earliest US approval1998
Market presence50 US product listings · 13 FDA applications · 6 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-008591
Legionella Pneumophila US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Fungal Proteins [CS]; Increased Histamine Release [PE]
Market presence4 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008592
Leishmania infantum excreted secreted proteins EU-MED Not yet graded
EU medicine: Withdrawn
Class as recordedQI07AO
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-008593
Lemborexant US-CSAUS-DRUG Not yet graded
CSA Schedule IVUS: drug for further processing
Class as recordedCytochrome P450 2B6 Inducers [MoA]; DEA: depressant; Orexin Receptor Antagonist [EPC]; Orexin Receptor Antagonists [MoA]
Earliest US approval2019
Market presence4 US product listings · 1 FDA applications
DEA other names(1R,2S)-2-[(2,4-Dimethylpyrimidin-5-yl)oxymethyl]-2-; (3-fluorophenyl)-N-(5-fluoropyridin-2-yl)cyclopropane-; 1-carboxamide
Recorded fromUS-CSA, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-008594
Lemna Minor CA-NHPEU-NOVELUS-DRUG Not yet graded
Not novel in supplementsCA licensed ingredientUS: otc monograph drug
Market presence13 US product listings · 25 Canadian licensed products
Parts in scopeExtracts on the basis of wine and bee honey prepared with Lemna minor
Recorded fromCA-NHP, EU-NOVEL, US-DRUG — 3 of 7 registers
Etalyn identifierETA-C-008595
Lemna Minor Whole US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Bee Venoms [CS]; Cell-mediated Immunity [PE]; Increased Histamine Release [PE]
Market presence8 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008596
Lemon US-DRUG Not yet graded
US: bla
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Fruit Proteins [EXT]
Market presence7 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008597
Lemon (Citrus limonium) - flavonoïdes EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
Claim as submittedRulingBasisOpinion
“Acts as a natural antioxidant. Helps to reduce oxidative stress. Helps to reduce aging effects. Necessary for cells protection. Improves the antioxidant defensive system.”Non-authorisedArt.13(1)EFSA opinion
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-008598
Lemon Bioflavonoids CA-NHP Not yet graded
CA licensed ingredient
Market presence9 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-008599
Lemon Extract CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-008600
Lemon Juice US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAcidifying Activity [MoA]; Allergens [CS]; Amino Acid [EPC]; Amino Acids [CS]
Market presence27 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008601
Lemon Oil US-DRUG Not yet graded
US: unapproved homeopathic
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008602
Lemongrass Oil CA-NHPUS-DRUG Not yet graded
CA licensed ingredientUS: unapproved homeopathic
Class as recordedLipid Emulsion [EPC]; Lipids [CS]
Market presence1 US product listings · 2 Canadian licensed products
Recorded fromCA-NHP, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-008603
Lenacapavir EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bulk ingredient
Class as recordedBreast Cancer Resistance Protein Inhibitors [MoA]; Cytochrome P450 3A Inhibitors [MoA]; HIV Capsid Inhibitors [MoA]; Human Immunodeficiency Virus 1 Capsid Inhibitor [EPC]
Earliest US approval2022
Market presence11 US product listings · 4 FDA applications · 2 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-008604
lenadogene nolparvovec EU-MED Not yet graded
EU medicine: Application withdrawn
Class as recordedS01
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-008605
Lenalidomide EU-MEDUS-DRUG Not yet graded
EU medicine: Application withdrawn, AuthorisedUS: anda
Class as recordedL04AX04; L04AX07; Thalidomide Analog [EPC]
Earliest US approval2005
Market presence135 US product listings · 21 FDA applications · 4 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-008606
Leniolisib Phosphate EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: nda
Class as recordedBreast Cancer Resistance Protein Inhibitors [MoA]; Cytochrome P450 1A2 Inhibitors [MoA]; Kinase Inhibitor [EPC]; L03AX22
Earliest US approval2023
Market presence1 US product listings · 1 FDA applications · 1 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-008607
Lenograstim US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAdrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Allergens [CS]; Antidote [EPC]
Market presence4 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008608
Lens culinaris CA-NHP Not yet graded
CA licensed ingredient
Market presence41 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-008609
Lens culinaris Medik. EU-NOVEL Not yet graded
Not novel in food
Parts in scopeLentil protein
Recorded fromEU-NOVEL — 1 of 7 registers
Etalyn identifierETA-C-008610
Lentil US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAdrenocorticotropic Hormone [CS]; Adrenocorticotropic Hormone [EPC]; Allergens [CS]; Cell-mediated Immunity [PE]
Market presence4 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008611
Lentil protein concentrate CA-NHP Not yet graded
CA licensed ingredient
Market presence3 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-008612
Lentinula edodes CA-NHPEU-CLAIMEU-NOVEL Not yet graded
Not novel in foodEU claims 0 authorised / 1 refusedCA licensed ingredient
Market presence848 Canadian licensed products
Parts in scopeFruiting body and aqueous extract powder; Dehydrated mycelium powder.; Mycelial extract
Claims examined by the EU — wording reproduced, not Etalyn’s.
Claim as submittedRulingBasisOpinion
“Contributes to natural immunological defences”Non-authorisedArt.13(1)EFSA opinion
Recorded fromCA-NHP, EU-CLAIM, EU-NOVEL — 3 of 7 registers
Etalyn identifierETA-C-008613
Lentinus Edodes CA-NHPEU-CLAIM Not yet graded
EU claims 0 authorised / 1 refusedCA licensed ingredient
Market presence19 Canadian licensed products
Claims examined by the EU — wording reproduced, not Etalyn’s.
Claim as submittedRulingBasisOpinion
“Contributes to natural immunological defences”Non-authorisedArt.13(1)EFSA opinion
Recorded fromCA-NHP, EU-CLAIM — 2 of 7 registers
Etalyn identifierETA-C-008614
Lenvatinib US-DRUG Not yet graded
US: bulk ingredient
Class as recordedKinase Inhibitor [EPC]; Receptor Tyrosine Kinase Inhibitors [MoA]
Earliest US approval2015
Market presence19 US product listings · 2 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008615
lenvatinib mesilate EU-MED Not yet graded
EU medicine: Authorised
Class as recordedL01XE; L01XE29
Market presence2 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-008616
Leodopa US-DRUG Not yet graded
Earliest US approval2025
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008617
Leontopodium Alpinum US-DRUG Not yet graded
US: unapproved drug other
Class as recordedAcidifying Activity [MoA]; Anti-coagulant [EPC]; Calcium Chelating Activity [MoA]; Calculi Dissolution Agent [EPC]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008618
Leonuri cardiacae herba EU-HERB Not yet graded
Herbal monograph: C: ongoing call for scientific data
also: Motherwort; Leonurus cardiaca L.
Class as recordedherbal: Circulatory disorders;Mental stress and mood disorders
Recorded fromEU-HERB — 1 of 7 registers
Etalyn identifierETA-C-008619
Leonurus Cardiaca CA-NHPUS-DRUG Not yet graded
CA licensed ingredientUS: unapproved homeopathic
Market presence2 US product listings · 96 Canadian licensed products
Recorded fromCA-NHP, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-008620
Leonurus Cardiaca Flowering TOP US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Increased Histamine Release [PE]
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008621
Leonurus Cardiaca Whole US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Calculi Dissolution Agent [EPC]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]
Market presence8 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008622
Leonurus heterophyllus CA-NHP Not yet graded
CA licensed ingredient
Market presence5 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-008623
Leonurus japonicus CA-NHP Not yet graded
CA licensed ingredient
Market presence217 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-008624
Lepidium apetalum CA-NHP Not yet graded
CA licensed ingredient
Market presence27 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-008625
Lepidium meyenii CA-NHP Not yet graded
CA licensed ingredient
Market presence2,023 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-008626
Lepidium Meyenii Root US-DRUG Not yet graded
US: otc monograph drug
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008627
Lepidium meyenii Walp. EU-NOVEL Not yet graded
Not novel in food
also: Lepidium peruvianum G. Chacón
Parts in scopeTubers
Recorded fromEU-NOVEL — 1 of 7 registers
Etalyn identifierETA-C-008628
Lepidium sativum CA-NHP Not yet graded
CA licensed ingredient
Market presence5 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-008629
Lepidolite CA-NHP Not yet graded
CA licensed ingredient
Market presence5 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-008630
lepirudin EU-MED Not yet graded
EU medicine: Withdrawn
Class as recordedB01AE02
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-008631
Leptadenia reticulata CA-NHP Not yet graded
CA licensed ingredient
Market presence7 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-008632
Leptandra CA-NHP Not yet graded
CA licensed ingredient
Market presence4 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-008633
Leptandra virginica CA-NHP Not yet graded
CA licensed ingredient
Market presence21 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-008634
Leptin Human US-DRUG Not yet graded
US: drug for further processing
Class as recordedAllergens [CS]; Blood Coagulation Factor [EPC]; Calcium [CS]; Calculi Dissolution Agent [EPC]
Market presence24 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008635
Leptinotarsa Decemlineata US-DRUG Not yet graded
US: unapproved homeopathic
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008636
Leptospermum scoparium CA-NHP Not yet graded
CA licensed ingredient
Market presence3 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-008637
Leptospermum scoparium Honey CA-NHP Not yet graded
CA licensed ingredient
Market presence21 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-008638
Leptospira CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-008639
leptospira and rabies virus EU-MED Not yet graded
EU medicine: Authorised
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-008640
Leptospira Interrogans EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: unapproved homeopathic
Market presence1 US product listings · 1 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-008641
Leptospira interrogans serogroup Australis serovar Bratislava EU-MED Not yet graded
EU medicine: Authorised
Market presence4 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-008642
Leptospira interrogans serogroup Canicola serovar Portland-vere (strain Ca-12-000) EU-MED Not yet graded
EU medicine: Authorised
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-008643
Leptospira kirschneri EU-MED Not yet graded
EU medicine: Authorised
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-008644
Lercanidipine Hydrochloride US-DRUG Not yet graded
US: bulk ingredient
Market presence3 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008645
leriglitazone EU-MED Not yet graded
EU medicine: Opinion
Class as recordedA16AX23
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-008646
Lerodalcibep EU-MEDUS-DRUG Not yet graded
EU medicine: OpinionUS: bla
Class as recordedC10AX
Market presence2 US product listings · 1 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-008647
Lerodalcibep-Liga US-DRUG Not yet graded
Earliest US approval2025
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008648
Lesinurad EU-MEDUS-DRUG Not yet graded
EU medicine: WithdrawnUS: bulk ingredient
Class as recordedM04AA51; M04AB05
Earliest US approval2015
Market presence1 US product listings · 2 FDA applications · 2 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-008649
Lespedeza capitata CA-NHP Not yet graded
CA licensed ingredient
Market presence5 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-008650
Lespedeza Capitata Flowering TOP US-DRUG Not yet graded
US: unapproved homeopathic
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008651
Lesser Galangal Root US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Food Additives [CS]
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008652
Lessertia frutescens CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-008653
Lessonia Nigrescens US-DRUG Not yet graded
US: unapproved drug other
Market presence3 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008654
Letermovir EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bulk ingredient
Class as recordedCytochrome P450 2C19 Inducers [MoA]; Cytochrome P450 2C8 Inhibitors [MoA]; Cytochrome P450 2C9 Inducers [MoA]; Cytochrome P450 3A Inhibitors [MoA]
Earliest US approval2017
Market presence13 US product listings · 4 FDA applications · 1 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-008655
Letibotulinumtoxina US-DRUG Not yet graded
US: bla
Class as recordedAcetylcholine Release Inhibitor [EPC]; Acetylcholine Release Inhibitors [MoA]; Neuromuscular Blockade [PE]; Neuromuscular Blocker [EPC]
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008656
Letibotulinumtoxina-Wlbg US-DRUG Not yet graded
Earliest US approval2024
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008657
Letrozole US-DRUG Not yet graded
US: anda
Class as recordedAromatase Inhibitor [EPC]; Aromatase Inhibitors [MoA]
Earliest US approval1997
Market presence36 US product listings · 24 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008658
Lettuce US-DRUG Not yet graded
US: bla
Class as recordedAdrenocorticotropic Hormone [CS]; Adrenocorticotropic Hormone [EPC]; Allergens [CS]; Blood Coagulation Factor [EPC]
Market presence5 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008659
Leucanthemum Vulgare Pollen US-DRUG Not yet graded
US: bla
Class as recordedAllergens [CS]; Animal Fur [CS]; Antigens; Cell-mediated Immunity [PE]
Market presence5 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008660
Leucanthemum Vulgare Whole US-DRUG Not yet graded
US: unapproved homeopathic
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008661
Leucas aspera CA-NHP Not yet graded
CA licensed ingredient
Market presence3 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-008662
Leucas mollissima var. chinensis CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-008663
Leucine CA-NHPUS-DRUG Not yet graded
CA licensed ingredientUS: anda
Class as recordedAcidifying Activity [MoA]; Adrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Adrenocorticotropic Hormone [CS]
Market presence80 US product listings · 1,969 Canadian licensed products
Recorded fromCA-NHP, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-008664
Leuconostoc lactis CA-NHP Not yet graded
CA licensed ingredient
Market presence5 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-008665
Leuconostoc mesenteroides CA-NHPEU-NOVEL Not yet graded
Not novel in foodCA licensed ingredient
also: Leuconostoc dextranicum; Leuconostoc mesenteroides ssp. cremoris; Leuconostoc mesenteroides ssp. dextranicum
Market presence14 Canadian licensed products
Parts in scopeWhole
Recorded fromCA-NHP, EU-NOVEL — 2 of 7 registers
Etalyn identifierETA-C-008666
Leuconostoc pseudomesenteroides CA-NHPEU-NOVEL Not yet graded
Not novel in foodCA licensed ingredient
Market presence26 Canadian licensed products
Parts in scopeWhole
Recorded fromCA-NHP, EU-NOVEL — 2 of 7 registers
Etalyn identifierETA-C-008667
Leuconostoc/radish Root Ferment Filtrate US-DRUG Not yet graded
US: otc monograph final
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Glycerol [CS]; Increased Histamine Release [PE]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008668
Leucovorin US-DRUG Not yet graded
US: anda
Class as recordedAcidifying Activity [MoA]; Anti-coagulant [EPC]; Ascorbic Acid [CS]; Calcium Chelating Activity [MoA]
Earliest US approval1952
Market presence83 US product listings · 59 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008669
Leuprolide US-DRUG Not yet graded
US: anda
Class as recordedGonadotropin Releasing Hormone Receptor Agonist [EPC]; Gonadotropin Releasing Hormone Receptor Agonists [MoA]
Earliest US approval1985
Market presence79 US product listings · 27 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008670
leuprorelin mesilate EU-MED Not yet graded
EU medicine: Authorised
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-008671
Leuzea carthamoide EU-NOVEL Not yet graded
Status not stated
Recorded fromEU-NOVEL — 1 of 7 registers
Etalyn identifierETA-C-008672
Leuzea Carthamoides Root US-DRUG Not yet graded
US: otc monograph final
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Glycerol [CS]; Increased Histamine Release [PE]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008673
Leuzea Rhapontica Root US-DRUG Not yet graded
US: unapproved homeopathic
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008674
Levacetylleucine US-DRUG Not yet graded
US: drug for further processing
Class as recordedBile Salt Export Pump Inhibitors [MoA]; Breast Cancer Resistance Protein Inhibitors [MoA]; Organic Anion Transporter 1 Inhibitors [MoA]; Organic Anion Transporter 3 Inhibitors [MoA]
Earliest US approval2024
Market presence2 US product listings · 1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008675
levacetylmethadol EU-MED Not yet graded
EU medicine: Withdrawn
Class as recordedN02AC
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-008676
Levalbuterol Tartrate US-DRUG Not yet graded
US: anda
Class as recordedAdrenergic beta2-Agonists [MoA]; beta2-Adrenergic Agonist [EPC]
Earliest US approval1999
Market presence45 US product listings · 14 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008677
Levallorphan Tartrate US-DRUG Not yet graded
Earliest US approval1956
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008678
Levamisole US-DRUG Not yet graded
US: bulk ingredient
Earliest US approval1990
Market presence9 US product listings · 1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008679
Levamlodipine Maleate US-DRUG Not yet graded
US: nda
Earliest US approval2019
Market presence2 US product listings · 1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008680
Levetiracetam EU-MEDUS-DRUG Not yet graded
EU medicine: Application withdrawn, AuthorisedUS: anda
Class as recordedDecreased Central Nervous System Disorganized Electrical Activity [PE]; N03AX14
Earliest US approval1999
Market presence348 US product listings · 112 FDA applications · 10 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-008681
Levilactobacillus Brevis CA-NHPEU-NOVEL Not yet graded
Not novel in foodCA licensed ingredient
also: Lactobacillus brevis
Market presence208 Canadian licensed products
Parts in scopeWhole
Recorded fromCA-NHP, EU-NOVEL — 2 of 7 registers
Etalyn identifierETA-C-008682
Levistici radix EU-HERB Not yet graded
Herbal monograph: F: Assessment finalised
also: Lovage root; Levisticum officinale W.D.J.Koch
Class as recordedherbal: Urinary tract and genital disorders
Recorded fromEU-HERB — 1 of 7 registers
Etalyn identifierETA-C-008683
Levisticum officinale CA-NHP Not yet graded
CA licensed ingredient
Market presence7 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-008684
Levisticum Officinale Leaf US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Bee Venoms [CS]; Cell-mediated Immunity [PE]; Increased Histamine Release [PE]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008685
Levisticum Officinale Root US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Bee Venoms [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]
Market presence5 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008686
Levmetamfetamine US-DRUG Not yet graded
US: bulk ingredient
Market presence9 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008687
Levo-alphacetylmethadol US-CSA Not yet graded
CSA Schedule IInarcotic
Class as recordedDEA: narcotic / opioid
DEA other namesLAAM; long acting methadone; levomethadyl acetate
Recorded fromUS-CSA — 1 of 7 registers
Etalyn identifierETA-C-008688
Levobetaxolol Hydrochloride US-DRUG Not yet graded
Earliest US approval2000
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008689
Levobunolol Hydrochloride US-DRUG Not yet graded
US: anda
Class as recordedAdrenergic beta-Antagonists [MoA]; beta-Adrenergic Blocker [EPC]
Earliest US approval1985
Market presence3 US product listings · 10 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008690
Levobupivacaine US-DRUG Not yet graded
US: bulk ingredient
Earliest US approval1999
Market presence3 US product listings · 1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008691
Levocabastine Hydrochloride US-DRUG Not yet graded
US: bulk ingredient
Earliest US approval1993
Market presence1 US product listings · 1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008692
Levocarnitine CA-NHPUS-DRUG Not yet graded
CA licensed ingredientUS: anda
Class as recordedAdrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Adrenocorticotropic Hormone [CS]; Adrenocorticotropic Hormone [EPC]
Earliest US approval1985
Market presence41 US product listings · 14 FDA applications · 83 Canadian licensed products
Recorded fromCA-NHP, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-008693
Levocetirizine Dihydrochloride US-DRUG Not yet graded
US: anda
Class as recordedHistamine H1 Receptor Antagonists [MoA]; Histamine-1 Receptor Antagonist [EPC]
Earliest US approval2007
Market presence107 US product listings · 29 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008694
Levodopa EU-MEDUS-DRUG Not yet graded
EU medicine: Authorised, OpinionUS: anda
Class as recordedAdrenocorticotropic Hormone [CS]; Adrenocorticotropic Hormone [EPC]; Allergens [CS]; Amino Acids
Earliest US approval1970
Market presence193 US product listings · 51 FDA applications · 7 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-008695
Levofloxacin EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: anda
Class as recordedJ01MA12
Earliest US approval1996
Market presence142 US product listings · 52 FDA applications · 1 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-008696
Levoketoconazole US-DRUG Not yet graded
US: bulk ingredient
Class as recordedCortisol Synthesis Inhibitor [EPC]; Cytochrome P450 11A1 Inhibitors [MoA]; Cytochrome P450 11B1 Inhibitors [MoA]; Cytochrome P450 17A1 Inhibitors [MoA]
Earliest US approval2021
Market presence6 US product listings · 1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008697
Levoleucovorin US-DRUG Not yet graded
US: anda
Class as recordedFolate Analog [EPC]; Folic Acid [CS]
Earliest US approval2008
Market presence18 US product listings · 15 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008698
Levomefolate Calcium US-DRUG Not yet graded
US: bulk ingredient
Class as recordedAcidifying Activity [MoA]; Allergens [CS]; Analogs/Derivatives [Chemical/Ingredient]; Anti-coagulant [EPC]
Earliest US approval2010
Market presence30 US product listings · 6 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008699
Levomefolate Glucosamine US-DRUG Not yet graded
US: unapproved drug other
Class as recordedAnalogs/Derivatives [Chemical/Ingredient]; Ascorbic Acid [CS]; Blood Coagulation Factor [EPC]; Calcium [CS]
Market presence6 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008700
Levomefolic Acid US-DRUG Not yet graded
US: unapproved drug other
Class as recordedAnalogs/Derivatives [Chemical/Ingredient]; Ascorbic Acid [CS]; Blood Coagulation Factor [EPC]; Calcium [CS]
Market presence5 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008701
Levomenol US-DRUG Not yet graded
US: otc monograph final
Class as recordedAcidifying Activity [MoA]; Allergens [CS]; Cell-mediated Immunity [PE]; Decreased Cell Wall Integrity [PE]
Market presence3 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008702
Levomenthol US-DRUG Not yet graded
US: bulk ingredient
Class as recordedAllergens [CS]; Amide Local Anesthetic [EPC]; Amides [CS]; Antiarrhythmic [EPC]
Market presence86 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008703
Levomepromazine US-DRUG Not yet graded
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008704
Levomepromazinum CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-008705
Levomethadyl Acetate Hydrochloride US-DRUG Not yet graded
Earliest US approval1993
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008706
Levomethorphan US-CSA Not yet graded
CSA Schedule IInarcotic
Class as recordedDEA: narcotic / opioid
Recorded fromUS-CSA — 1 of 7 registers
Etalyn identifierETA-C-008707
Levomilnacipran US-DRUG Not yet graded
US: bulk ingredient
Class as recordedNorepinephrine Uptake Inhibitors [MoA]; Serotonin Uptake Inhibitors [MoA]; Serotonin and Norepinephrine Reuptake Inhibitor [EPC]
Earliest US approval2013
Market presence14 US product listings · 7 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008708
Levomoramide US-CSA Not yet graded
CSA Schedule Inarcotic
Class as recordedDEA: narcotic / opioid
Recorded fromUS-CSA — 1 of 7 registers
Etalyn identifierETA-C-008709
Levonordefrin US-DRUG Not yet graded
US: bulk ingredient
Earliest US approval1952
Market presence1 US product listings · 7 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008710
Levonorgestrel US-DRUG Not yet graded
US: anda
Class as recordedEstradiol Congeners [CS]; Estrogen Receptor Agonists [MoA]; Estrogen [EPC]; Inhibit Ovum Fertilization [PE]
Earliest US approval1979
Market presence90 US product listings · 112 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008711
Levophenacylmorphan US-CSA Not yet graded
CSA Schedule Inarcotic
Class as recordedDEA: narcotic / opioid
Recorded fromUS-CSA — 1 of 7 registers
Etalyn identifierETA-C-008712
Levopropoxyphene Napsylate Anhydrous US-DRUG Not yet graded
Earliest US approval1962
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008713
Levorphanol US-CSAUS-DRUG Not yet graded
CSA Schedule IInarcoticUS: anda
Class as recordedDEA: narcotic / opioid; Full Opioid Agonists [MoA]; Opioid Agonist [EPC]
Earliest US approval1953
Market presence14 US product listings · 7 FDA applications
DEA other namesLevo-Dromoran
Recorded fromUS-CSA, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-008714
Levothyroxine US-DRUG Not yet graded
US: anda
Class as recordedAcidifying Activity [MoA]; Adrenocorticotropic Hormone [CS]; Adrenocorticotropic Hormone [EPC]; Allergens [CS]
Earliest US approval2000
Market presence699 US product listings · 34 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008715
Levure de bière EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
Claim as submittedRulingBasisOpinion
“Contribue à la beauté de la peau Favorise l'éclat et la vitalité de la peau”Non-authorisedArt.13(1)EFSA opinion
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-008716
Leymus Condensatus Pollen US-DRUG Not yet graded
US: bla
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Increased Histamine Release [PE]; Increased IgG Production [PE]
Market presence4 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008717
LGG® MAX multispecies probiotic consisting of four bacterial strains EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
Claim as submittedRulingBasisOpinion
“LGG® MAX helps to reduce gastro-intestinal discomfort”Non-authorisedArt.13(5)EFSA opinion
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-008718
Liatris spicata CA-NHP Not yet graded
CA licensed ingredient
Market presence6 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-008720
Liatris Spicata Root US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Increased Histamine Release [PE]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008721
Lichen islandicus EU-HERB Not yet graded
Herbal monograph: F: Assessment finalised
also: Iceland moss; Cetraria islandica (L.) Acharius s.l.
Class as recordedherbal: Loss of appetite;Mouth and throat disorders;Cough and cold
Recorded fromEU-HERB — 1 of 7 registers
Etalyn identifierETA-C-008722
Licorice CA-NHPUS-DRUG Not yet graded
CA licensed ingredientUS: unapproved drug other
Class as recordedAllergens [CS]; Analogs/Derivatives [Chemical/Ingredient]; Cell-mediated Immunity [PE]; Copper Absorption Inhibitor [EPC]
Market presence13 US product listings · 4 Canadian licensed products
Recorded fromCA-NHP, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-008723
Lidocaine EU-MEDUS-DRUG Not yet graded
EU medicine: Authorised, WithdrawnUS: anda
Class as recordedAdrenergic alpha-Agonists [MoA]; Adrenergic alpha1-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Allergens [CS]
Earliest US approval1948
Market presence1,804 US product listings · 205 FDA applications · 2 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-008724
Lidocaine HCL US-DRUG Not yet graded
US: otc monograph drug
Class as recordedAdrenergic alpha1-Agonists [MoA]; Amide Local Anesthetic [EPC]; Amides [CS]; Antiarrhythmic [EPC]
Market presence12 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008725
Lifileucel EU-MEDUS-DRUG Not yet graded
EU medicine: Application withdrawnUS: bla
Class as recordedL01XL11
Market presence1 US product listings · 1 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-008726
Lifitegrast EU-MEDUS-DRUG Not yet graded
EU medicine: Application withdrawnUS: anda
Class as recordedLymphocyte Function-Associated Antigen-1 Antagonist [EPC]; Lymphocyte Function-Associated Antigen-1 Antagonists [MoA]; S01XA25
Earliest US approval2016
Market presence16 US product listings · 5 FDA applications · 1 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-008727
Ligandrol ETALYN D/supportedband 6
also: VK5211; LGD-4033
Recorded from — 0 of 7 registers
Etalyn identifierETA-C-008728
Light Mineral Oil US-DRUG Not yet graded
US: bulk ingredient
Market presence25 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008729
Ligilactobacillus salivarius CA-NHPEU-NOVEL Not yet graded
Not novel in foodCA licensed ingredient
also: Lactobacillus salivarius
Market presence801 Canadian licensed products
Parts in scopeWhole
Recorded fromCA-NHP, EU-NOVEL — 2 of 7 registers
Etalyn identifierETA-C-008730
Lignans CA-NHPEU-CLAIM Not yet graded
EU claims 0 authorised / 1 refusedCA licensed ingredient
Market presence2 Canadian licensed products
Claims examined by the EU — wording reproduced, not Etalyn’s.
Claim as submittedRulingBasisOpinion
“Phytonutrients that show similar attributes to phytoestrogens in soya.”Non-authorisedArt.13(1)EFSA opinion
Recorded fromCA-NHP, EU-CLAIM — 2 of 7 registers
Etalyn identifierETA-C-008731
Lignosus rhinocerus Cooke EU-NOVEL Not yet graded
Novel, not yet authorised
Parts in scopeFruiting body, mycelium and sclerotium
Recorded fromEU-NOVEL — 1 of 7 registers
Etalyn identifierETA-C-008732
Ligularia stenocephala CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-008733
Ligusticum canadense CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-008734
Ligusticum chuanxiong CA-NHP Not yet graded
CA licensed ingredient
Market presence81 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-008735
Ligusticum chuanxiong Hort CA-NHP Not yet graded
CA licensed ingredient
Market presence11 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-008736
Ligusticum jeholense CA-NHP Not yet graded
CA licensed ingredient
Market presence34 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-008737
Ligusticum porteri CA-NHP Not yet graded
CA licensed ingredient
Market presence20 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-008738
Ligusticum Porteri Root US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Ascorbic Acid [CS]; Calculi Dissolution Agent [EPC]; Cell-mediated Immunity [PE]
Market presence6 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008739
Ligusticum sinense CA-NHP Not yet graded
CA licensed ingredient
Market presence169 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-008740
Ligusticum sinense cv. chuanxiong CA-NHP Not yet graded
CA licensed ingredient
Market presence1,495 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-008741
Ligusticum sinense Oliv. CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-008742
Ligusticum Sinense Subsp. Chuanxiong Root US-DRUG Not yet graded
US: unapproved drug other
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008743
Ligusticum sinense var sinense CA-NHP Not yet graded
CA licensed ingredient
Market presence20 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-008744
Ligusticum striatum EU-NOVEL Not yet graded
Not novel in supplements
also: Szechuan lovage; Ligusticum chuanxiong S.H.Qiu, Y.Q.Zeng, K.Y.Pan, Y.C.Tang & J.M.Xu , Ligusticum wallichii Franch.
Parts in scopeRoot/rhizome and its alcoholic extract
Recorded fromEU-NOVEL — 1 of 7 registers
Etalyn identifierETA-C-008745
Ligusticum wallichii CA-NHP Not yet graded
CA licensed ingredient
Market presence3 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-008746
Ligustrum lucidum CA-NHP Not yet graded
CA licensed ingredient
Market presence248 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-008747
Ligustrum Lucidum Fruit US-DRUG Not yet graded
US: otc monograph drug
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008748
Ligustrum Lucidum Seed US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAdrenocorticotropic Hormone [CS]; Adrenocorticotropic Hormone [EPC]; Allergens [CS]; Cell-mediated Immunity [PE]
Market presence3 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008749
Ligustrum vulgare CA-NHP Not yet graded
CA licensed ingredient
Market presence6 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-008750
Ligustrum Vulgare Pollen US-DRUG Not yet graded
US: bla
Class as recordedAdrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Allergens [CS]; Catecholamine [EPC]
Market presence41 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008751
Ligustrum Vulgare Whole US-DRUG Not yet graded
US: unapproved homeopathic
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008752
Lilium brownii CA-NHP Not yet graded
CA licensed ingredient
Market presence116 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-008753
Lilium brownii var. viridulum CA-NHP Not yet graded
CA licensed ingredient
Market presence6 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-008754
Lilium candidum CA-NHP Not yet graded
CA licensed ingredient
Market presence3 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-008755
Lilium lancifolium CA-NHP Not yet graded
CA licensed ingredient
Market presence45 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-008756
Lilium Lancifolium Bulb US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Bee Venoms [CS]; Cell-mediated Immunity [PE]; Increased Histamine Release [PE]
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008757
Lilium Lancifolium Flowering TOP US-DRUG Not yet graded
US: drug for further processing
Class as recordedAdrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Catecholamine [EPC]; Catecholamines [CS]
Market presence3 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008758
Lilium Lancifolium Whole US-DRUG Not yet graded
US: drug for further processing
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008759
Lilium Lancifolium Whole Flowering US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAdrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Allergens [CS]; Androgen Receptor Agonists [MoA]
Market presence71 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008760
Lilium Longiflorum Bulb US-DRUG Not yet graded
US: unapproved homeopathic
Market presence8 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008761